Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival.

Date publication

mai 2019

Journal

JAMA dermatology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr AUBIN François , Dr GRANEL-BROCARD Florence

Tous les auteurs :
Vallet A, Oriano B, Mortier L, Dalle S, Dutriaux C, Guillot B, Leccia MT, Dalac S, Saiag P, Lacour JP, Legoupil D, De Quatrebarbes J, Brunet-Possenti F, Lesimple T, Arnault JP, Aubin F, Granel-Brocard F, Stoebner PE, Maubec E, Dreno B, Allayous C, Porcher R, Lebbé C,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31042256

Résumé

The prognosis of advanced melanoma has been greatly improved by new therapeutic agents and clinicians rely on dynamic signals to drive their therapeutic choices. Although the kinetics of metastatic disease seem to be correlated with survival, progression of the localized disease is not predictable.

Référence

JAMA Dermatol. 2019 May 1;: